Benzinga | Feb 18, 2021 04:29PM EST

Emergent BioSolutions Q4 Adj. EPS $3.67 Beats $3.19 Estimate, Sales $583.00M Beat $563.60M Estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $3.67 per share which beat the analyst consensus estimate of $3.19 by 15.05 percent. This is a 133.76 percent increase over earnings of $1.57 per share from the same period last year. The company reported quarterly sales of $583.00 million which beat the analyst consensus estimate of $563.60 million by 3.44 percent. This is a 61.76 percent increase over sales of $360.40 million the same period last year.